BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5768437)

  • 1. The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):210-26. PubMed ID: 5768437
    [No Abstract]   [Full Text] [Related]  

  • 2. The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):227-34. PubMed ID: 5768439
    [No Abstract]   [Full Text] [Related]  

  • 3. The selectivity of action of alkylating agents and drug resistance. 3. The uptake and degradation of alkylating drugs by Yoshida ascites sarcoma cells in vitro.
    Harrap KR; Hill BT
    Biochem Pharmacol; 1970 Jan; 19(1):209-17. PubMed ID: 5507636
    [No Abstract]   [Full Text] [Related]  

  • 4. The absorption, distribution and excretion of 3 H-chlorambucil in rats bearing the Yoshida ascites sarcoma.
    Hill BT; Riches PG
    Br J Cancer; 1971 Dec; 25(4):831-7. PubMed ID: 5144543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some effects of chlorambucil on enzymes of glutathione metabolism in drug-sensitive and -resistant strains of the Yoshida ascites sarcoma.
    Harrap KR; Jackson RC; Hill BT
    Biochem J; 1969 Feb; 111(4):603-6. PubMed ID: 5774483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chlorambucil on the incorporation of tritiated precursors into the nucleic acids and proteins of Yoshida ascites sarcoma cells.
    Hill BT; Harrap KR
    Neoplasma; 1970; 17(5):485-9. PubMed ID: 5486299
    [No Abstract]   [Full Text] [Related]  

  • 7. Selectivity of action of alkylating agents and drug resistance. 4. Synthesis of tritium-labeled chlorambucil and a study of its cellular uptake by drug-sensitive and drug-resistant strains of the Yoshida ascites sarcoma in vitro.
    Hill BT; Jarman M; Harrap KR
    J Med Chem; 1971 Jul; 14(17):614-8-. PubMed ID: 5164451
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of sarcolysin with histones of Yoshida's sarcoma of strains sensitive and resistant to alkylating agents.
    Panosyan GA
    Bull Exp Biol Med; 1974 Jun; 76(12):1442-4. PubMed ID: 4421340
    [No Abstract]   [Full Text] [Related]  

  • 9. Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells.
    Riches PG; Harrap KR
    Cancer Res; 1973 Feb; 33(2):389-93. PubMed ID: 4688885
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of the nuclear reactivity of alkylating agents by prednisolone.
    Wilkinson R; Birbeck MS; Harrap KR
    Cancer Res; 1979 Oct; 39(10):4256-62. PubMed ID: 476658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of melphalan on a sensitive and a resistant Yoshida ascites tumour.
    Cooper EH; Tipping NE
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):40-50. PubMed ID: 5659735
    [No Abstract]   [Full Text] [Related]  

  • 12. The binding of (3H)chlorambucil to isolated nuclear proteins of the Yoshida ascites sarcoma.
    Sellwood SM; Riches PG; Harrap KR
    Biochem Soc Trans; 1975; 3(5):649-51. PubMed ID: 1193258
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of resistance to alkylating agents of three ascites tumours in the rat.
    Poynter RW
    Biochem Pharmacol; 1970 Apr; 19(4):1387-97. PubMed ID: 4327763
    [No Abstract]   [Full Text] [Related]  

  • 14. Some effects of chlorambucil on nuclear protein phosphorylation in the Yoshida ascites sarcoma.
    Riches PG; Sellwood SM; Harrap KR
    Chem Biol Interact; 1977 Jul; 18(1):11-22. PubMed ID: 890836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chlorambucil treatment on the rates of respiration and glycolysis in drug-sensitive and -resistant strains of the Yoshida ascites sarcoma.
    Hill BT; Riches PG; Furness ME
    Biochem Pharmacol; 1970 Dec; 19(12):2973-8. PubMed ID: 5534949
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased antitumour activity of chlorambucil following pretreatment with inducers of drug-metabolizing enzymes.
    Hill BT; Douglas ID; Grover PL
    Biochem Pharmacol; 1973 May; 22(9):1083-9. PubMed ID: 4695667
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of the toxicity of "radiomimetic" alkylating agents by thiol pretreatment. VI. The mechanism of protection by cysteine.
    Ball CR; Connors TA
    Biochem Pharmacol; 1967 Mar; 16(3):509-19. PubMed ID: 6034367
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of cytotoxic concentrations of chlorambucil on drug-resistant and drug-sensitive cell lines of the Yoshida ascites sarcoma in culture.
    Hill BT
    Eur J Cancer (1965); 1975 Jan; 11(1):91-6. PubMed ID: 1169147
    [No Abstract]   [Full Text] [Related]  

  • 19. The sensitivity of a Yoshida sarcoma to methylene dimethane sulphonate.
    Fox BW
    Int J Cancer; 1969 Jan; 4(1):54-60. PubMed ID: 5346476
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of nitrogen-mustard sensitive and -resistant Yoshida sarcomas.
    Ball CR; Connors TA; Double JA; Ujhazy V; Whisson ME
    Int J Cancer; 1966 Jul; 1(4):319-27. PubMed ID: 5911173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.